Grifols, Brookfield
Brookfield still hasn't managed to obtain the €9.5 billion of bank financing to repay Grifols’ debt, nor the €3.5 billion ...
EST Brookfield still pursuing Grifols (GRFS) deal, Bloomberg reports Published first on TheFly – the ultimate source for ...
Brookfield Asset Management is in talks with several investment funds as part of the proposed acquisition of the Spanish blood plasma company Grifols SA. This is reported in a Brookfield press ...
Brookfield fund has failed to raise the nearly €10,000 million needed to acquire 70% of the company and restructure the debt.
Four people were taken to the hospital after a crash in Brookfield on Saturday. Emergency crews responded to the 100 block of Junction Road around 1 p.m. for a crash with injuries. According to ...
International Assets Investment Management LLC acquired a new position in Grifols, S.A. (NASDAQ:GRFS – Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC.
Global healthcare company Grifols has partnered with BARDA, the Biomedical Advanced Research and Development Authority, to develop the first immune therapy eye drops to prevent the long-term ...
Overview: Grifols, S.A. is a plasma therapeutic company operating in Spain, the United States, Canada, and internationally with a market cap of approximately €6.40 billion. Operations: Grifols ...
The company has a 50 day moving average of $8.82 and a 200 day moving average of $7.77. Grifols has a twelve month low of $5.30 and a twelve month high of $12.15. Get Grifols alerts: Grifols ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback